New research links noninvasive brain blood flow and oxygenation markers to hallmark Alzheimer's disease changes, suggesting early risk detection potential.
Key Details
- 1Study conducted at the Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC.
- 2Researchers used transcranial Doppler ultrasound and near-infrared spectroscopy to measure brain blood flow and oxygenation.
- 3Findings associated higher vascular function indicators with lower amyloid plaques and larger hippocampal volume.
- 4Amyloid PET imaging was also used to correlate vascular markers with known AD pathology.
- 5Techniques are less costly and more tolerable for large-scale or difficult-to-image populations than MRI or PET.
- 6Longitudinal studies are underway to assess if changes in these markers can predict cognitive decline.
Why It Matters
Demonstrating a link between vascular brain health (measured noninvasively) and established Alzheimer’s imaging findings could enable earlier and easier risk stratification. The use of noninvasive, accessible tools may facilitate broad screening and intervention research in populations unable to tolerate extensive imaging.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.